Orthopedic Digit Implants Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Orthopedic Digit Implants Market size was valued at around USD 387.2 million in 2022 and is estimated to grow at over 6.2% CAGR between 2023 and 2032. The increasing prevalence of orthopedic diseases, surging preference for minimally invasive surgeries, and technological advancements in orthopedic digit implants are some of the key factors driving the market growth.
The rising incidence of orthopedic diseases, such as osteoarthritis, rheumatoid arthritis, and traumatic injuries, has spurred an increased demand. These health conditions often require the use of orthopedic digit implants to provide support, stability, and assistance in managing functional limitations associated with various orthopedic conditions. According to the World Health Organization, in 2019, approximately 528 million people worldwide were living with osteoarthritis, marking a 113% increase since 1990.
The significant and escalating number of individuals living with various orthopedic conditions, resulting in functional limitations, is attributed to rapid population growth and an increase in the aging population. Consequently, the substantial disease burden and the high prevalence of related disorders are expected to propel the growth of the market in the near future.
Orthopedic digit implants refer to specialized orthopedic devices or prosthetics component designed to address various orthopedic conditions affecting the fingers and toes. These implants are specifically crafted to provide support, stability, and functional assistance to individuals experiencing musculoskeletal discomfort, deformities, or limitations in their digital joints.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Orthopedic Digit Implants Market size in 2022: | USD 387.2 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 6.2 |
2023 Value Projection: | USD 695.5 Million |
Historical Data for: | 2018 to 2022 |
No of Pages: | 160 |
Tables, Charts & Figures: | 217 |
Segments Covered: | Product Type, Material, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The post-surgery complications related to orthopedic digit implant procedures may impact both patient outcomes and market dynamics. Complications such as infections, implant rejection, malalignment, limited range of motion, and issues related to implant durability can hinder the intended benefits of these innovative solutions designed to enhance digit functionality post-amputation.
The emergence of the COVID-19 pandemic marked an unparalleled occurrence that significantly affected public health, resulting in a sharp increase in hospitalizations. The pandemic had adverse effects on the healthcare system, necessitating the widespread reassignment of healthcare personnel. Consequently, this resulted in the postponement of diagnosis and treatment of orthopedic disorders and other related conditions as these procedures require close contact with the patients that may increase the risk of infection to practitioners and other patients. As a result, the market experienced a decline in growth throughout 2020.
Rising advancements in orthopedic digit implants intended to improve the functionality, durability, and overall performance to better meet the needs of individuals who have undergone digit amputations will spur the business growth.
Based on product type, the market is segmented into metatarsal joint implants, metacarpal joint implants, hemi phalangeal implants, scaphoid bone implants, and toe intramedullary implants. The metatarsal joint implants segment was valued at around USD 387.2 million in 2022 and is expected to exhibit a robust growth trend throughout the analysis period.
Based on material, the orthopedic digit implants market is segmented as titanium, nitinol, silicon pyrocarbon, and others. The titanium segment held the largest revenue share in 2022 and was valued at USD 159.8 million and is projected to expand at a CAGR of 6.2% during the forecast period to reach a market value of USD 288.5 million by 2032.
Based on end-use, the orthopedic digit implants market is segmented into hospitals and orthopedic clinics. The hospitals segment held a significant share in 2022 and is projected to reach more than USD 490.3 million by 2032.
The U.S. dominated the North America orthopedic digit implants market with a significant market share in 2022 and is anticipated to expand at a notable pace to reach more than USD 285 million by 2032.
The orthopedic digit implants industry is consolidated in nature, with companies competing to offer superior orthopedic digit implants in this business space. Prominent players such as Smith & Nephew, Stryker Corporation, and Johnson & Johnson hold a significant share in this market. These companies are diligently directing their efforts towards continuous type innovation to gain substantial market share.
Some of the eminent market participants operating in the orthopedic digit implants industry include:
By Product Type, 2018 - 2032 (USD Million)
By Material, 2018 - 2032 (USD Million)
By end-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries:
Smith & Nephew, Stryker Corporation, Johnson & Johnson, Arthrex GmbH, Merete GmbH, Acumed LLC, Vilex, LLC, Zimmer Biomet, Wright Medical, and Anika Therapeutics, Inc. are some of the major orthopedic digit implants companies worldwide.
U.S. orthopedic digit implants industry is expected to record USD 285 million by 2032 due to the presence of leading industry players, increasing demand for orthopedic digit implants, and the rising incidence of orthopedic diseases in the region.
Orthopedic digit implants industry from the metatarsal joint implants segment reached USD 387.2 million in 2023 owing to the rising burden of arthritis, deformities, and traumatic injuries.
Orthopedic digit implants industry size was USD 387.2 million in 2023 and is expected to reach over USD 695.5 million by 2032 owing to increasing prevalence of orthopedic diseases, surging preference for minimally invasive surgeries, and technological advancements in orthopedic digit implants.